OpenVSafe by OpenVAERS
Search V-safe

VKF-15701-46921

4 vaccinations 1 coded response 15 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
913 / CA
Registered
2021-05-03
Relationship
Self
Race
N/A
Ethnicity
Hispanic or Latino
Registered dependents
YER-20205-31576 Child or adolescent in my care · Female · 2022-12-05
BLW-86646-34197 Child or adolescent in my care · Female · 2022-12-18

Timeline

  1. 2021-04-11
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-02
    Dose 2 — Pfizer-BioNTech
  3. 2021-05-03
    Registered in v-safe
  4. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-05-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-05-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-05-09
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-08-01
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-10-31
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  13. 2021-12-03
    Dose 3 — Pfizer-BioNTech
  14. 2022-01-14
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-03-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-06-03
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-10-07
    Dose 4 — Pfizer-BioNTech
  18. 2022-12-05
    Survey response — 12 months, dose 3
    MedDRA: Hyperthyroidism, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Hyperthyroid · Healthcare visit (other): Doctor visits
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-12-05
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  20. 2022-12-06
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  21. 2023-01-06
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  22. 2023-04-07
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-11Pfizer-BioNTech
22021-05-02Pfizer-BioNTech
32021-12-03Pfizer-BioNTech No
42022-10-07Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-12-05 Successful
2022-12-06
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 — 12 months, dose 3

2022-12-05

Symptoms: Hyperthyroid
Healthcare visit (other): Doctor visits

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDHyperthyroidism · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…